跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 70,446 条关于
“dual GLP-1/GIP agonists”
全部
70,446
临床试验
42,934
药物
8,594
机构
1,469
资讯
17,449
7个月前
GLP-1 Agonists Show Promise in Reducing Sleep Apnea Risk and Improving Cardiometabolic Outcomes
去年
Hengrui and Kailera Present Phase 2 Data for Dual GLP-1/GIP Agonist and Oral GLP-1 Therapies at ADA 2025
去年
FDA Advised to Update Labels on GLP-1 Weight-Loss Drugs for Broader Applicability
去年
Viking Therapeutics Advances Novel Oral GLP-1/GIP Dual Agonist VK2735 to Phase 2 Trial for Obesity Treatment
上个月
Weight-Loss Medications Not Linked to Higher Respiratory Adverse Event Risk, Meta-Analysis Finds
11个月前
Chugai Licenses Roche's CT-388 Dual GLP-1/GIP Receptor Agonist for Japan Market
去年
Regeneron Licenses Chinese GLP-1/GIP Dual Agonist in $2 Billion Obesity Deal with Hansoh Pharma
5个月前
BrightGene's Oral GLP-1/GIP Dual Agonist BGM0504 Shows Promising Weight Loss Results in Phase 1 Trials
3年前
Emerging Role of GLP-1 Agonists in Obesity
去年
Hengrui and Kailera's Dual GLP-1/GIP Obesity Drug Achieves 18% Weight Loss in Phase 3 Trial
第 1 页,共 1745 页
上一页
下一页